Invesco Ltd. quarterly report, Q3 FY2020

Invesco Ltd. — Q3 2020 Form 10-Q

Reporting period: Quarter and nine months ended September 30, 2020. Invesco is a global investment manager. Amounts are in U.S. dollars; financial amounts are in millions unless stated otherwise.

Financial performance

MetricQ3 2020Q3 2019Nine months 2020Nine months 2019
Operating revenue$1,497.6$1,720.6$4,515.5$4,374.6
Operating income$268.5$275.1$702.6$493.6
Operating margin17.9%16.0%15.6%11.3%
Net income attributable to Invesco$191.7$167.1$313.7$384.9
Diluted EPS$0.41$0.36$0.68$0.89
Net cash from operating activitiesNot provided by quarter$662.7$669.3

Q3 GAAP revenue fell 13.0% year over year, while operating income declined 2.4% and net income attributable to Invesco rose 14.7%. For the nine-month period, revenue increased 3.2%, operating income increased 42.4%, and attributable net income fell 18.5%. Nine-month results include OppenheimerFunds only from its May 2019 acquisition date, making comparisons less directly comparable.

Non-GAAP net revenue was $1,092.5 in Q3, down 11.1%, and $3,272.6 for nine months, up 4.0%. Adjusted operating income was $406.7 in Q3, down from $502.6, and $1,179.1 for nine months, up from $1,150.3. Adjusted operating margin was 37.2% and 36.0%, respectively, versus 40.9% and 36.5%. Adjusted diluted EPS was $0.53 in Q3 and $1.21 for nine months, versus $0.70 and $1.91. These are non-GAAP measures and should be read with the filing’s reconciliations.

AUM, liquidity and debt

  • Quarter-end AUM was $1.218 trillion, up from $1.184 trillion a year earlier. Q3 average AUM was $1.206 trillion, up from $1.188 trillion; management reported $7.8 billion in long-term net inflows for the quarter. Nine-month long-term net flows were negative $25.5 billion.
  • Q3 net revenue yield declined to 36.2 basis points from 41.4 basis points a year earlier. Invesco attributed pressure to shifts toward passive and other lower-fee products, including growth in QQQ; management expected near-term revenue-yield pressure to continue.
  • Cash and cash equivalents were $1,066.6 at September 30, 2020, compared with $1,049.0 at year-end 2019. Nine-month operating cash flow was $662.7; investing cash flow was negative $829.0 and financing cash flow negative $230.3. The reported cash-flow statement includes consolidated investment products (CIP); the company’s cash excluding CIP was $1,066.6.
  • Long-term debt was $2,172.0, including $90.0 drawn under a $1.5 billion credit facility. Invesco reduced the facility balance from $325.6 at June 30. It reported compliance with covenants, a 1.43x leverage ratio and 10.94x interest coverage ratio. Most borrowings had fixed rates.
  • Management said available cash, operating cash flow, credit-facility capacity and potential capital-market access should support expected needs. The company did not foresee further share repurchases in 2020 and expected to redeem approximately $200 million of seed investments during the year.

Material changes and unusual items

  • Operating expenses declined 15.0% in Q3 and 1.8% for the nine months. Lower transaction and integration charges contributed to the year-over-year decline; pandemic-related reductions in travel and business activity were described as temporary.
  • Nine-month general and administrative expense included a $105.3 charge for compensating two funds after a delayed S&P 500 equal-weight index rebalance. Invesco said it would seek insurance recovery, but the amount and timing were uncertain.
  • An OppenheimerFunds-related accounting matter involving restated NAVs for four MLP funds led to an estimated $387.8 liability for pre- and post-acquisition activity, including $380.5 reflected in acquisition accounting and $7.3 recorded in earnings. Remediation costs and the extent of Invesco’s ultimate responsibility remained uncertain; estimates excluded possible insurance and seller-indemnity recoveries.
  • Management’s strategic expense review targeted $200 million of permanent annual net operating expense improvements. It expected $150 million by the end of 2021 and the remainder by the end of 2022, with estimated restructuring costs of $250–$275 million over two years.
  • COVID-19 market volatility affected AUM, yields, client-product liquidity and operating conditions. Other cited uncertainties included Brexit, U.S.–China tensions, foreign-exchange movements and the transition from LIBOR, whose publication beyond 2021 was not guaranteed.

Contingencies and other disclosures

  • Undrawn co-investment commitments were $385.1. Approximately $322.7 of MassMutual seed investments were subject to redemption rights that could require Invesco to fund a redemption temporarily if a fund could not meet it.
  • Management stated that litigation accruals were adequate for estimable matters and that it could not estimate a range of reasonably possible losses for other litigation contingencies.
  • Quarterly dividends declared after quarter-end were $0.155 per common share and $14.75 per preferred share. Preferred shares carry a 5.9% annual dividend rate, payable when declared.
  • Management reported disclosure controls were effective and no material change in internal control over financial reporting during the nine months.

Most important facts for investors to verify

  • Whether AUM flows and market conditions stabilize, and whether fee-mix changes continue to reduce revenue yield.
  • The final remediation exposure, insurance proceeds and any MassMutual indemnification related to the MLP fund NAV matter.
  • Progress, timing, and realized costs of the $200 million annual expense-improvement plan.
  • Cash generation and debt reduction, while separating Invesco’s own liquidity from CIP assets and liabilities, which are not generally available to or obligations of the company.
  • Whether the $105.3 fund-rebalancing payment is recovered and whether further operational or compliance issues arise.